Infectious Diseases 1405 - Infectious Disease Alert - May 01, 2010

Target Audience:

This activity is intended for the infectious disease specialist.


AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Physician Editor
Stan Deresinski, MD, FACP
Clinical Professor of Medicine
Associate Chief of Infectious Diseases
Santa Clara Valley Medical Center

Board Member and Peer Reviewer
Connie Price, MD
Assistant Professor
University of Colorado School of Medicine

Board Member and Updates Author
Carol A. Kemper, MD, FACP
Clinical Associate Professor of Medicine
Stanford University
Division of Infectious Diseases
Santa Clara Valley Medical Center
Section Editor, Updates
Section Editor, HIV

Associate Editors
Hal B. Jenson, MD, FAAP
Professor of Pediatrics
Tufts University School of Medicine
Chief Academic Officer
Baystate Medical Center
Springfield, MA

Dean L. Winslow, MD, FACP, FIDSA
Chief, Division of AIDS Medicine
Santa Clara Valley Medical Center
Clinical Professor
Stanford University School of Medicine
Section Editor, HIV

Robert Muder, MD
Hospital Epidemiologist
Pittsburgh VA Medical Center
Section Editor Hospital Epidemiology

Ellen Jo Baron, PhD, D(ABMM)
Professor Emerita
Stanford University School of Medicine Interim Director
Clinical Virology Laboratory


  • Ivermectin for Head Lice
  • Etiology of Sepsis in Patients Admitted from the ED
  • Chlorhexidine-Alcohol Is Superior to Povidone-Iodine for Pre-op Prep
  • Pneumococcal Conjugate Vaccine Is Effective in HIV-infected Patients
  • Antiretroviral Initiation During or Following Treatment of TB
  • Changing Pneumococcal Serotypes Causing Disease
  • Increasing Herpes Zoster Among Veterans: An Unintended Consequence of the VZV Vaccine?
  • Invasive Fungal Infections in Transplant Recipients
  • Updates


  • discuss the diagnosis and treatment of infectious diseases
  • explain current data regarding the use of new antibiotics for commonly diagnosed diseases and new uses for traditional drugs
  • discuss the latest information regarding risks, benefits and cost-effectiveness of new and traditional diagnostic tests
  • discuss new information regarding how infectious diseases are transmitted and how such information can lead to the development of new therapies

Financial Disclosure:

Infectious Disease Alert's Physician Editor, Stan Deresinski, MD, FACP, serves on the speaker’s bureau for Merck, Pfizer, Wyeth, Ortho-McNeil (J&J), Schering-Plough, and Cubist, does research for the National Institute of Health, and is an advisory board member for Schering-Plough, Ortho-McNeil (J&J), and Cepheid. Peer Reviewer Connie Price, MD, Associate Editors Hal B. Jenson, MD, FAAP, and Ellen Jo Baron, PhD, D(ABMM), report no consultant, stockholder, speaker's bureau, research, or other financial relationship with any company related to this field of study. Updates Author Carol A. Kemper, MD, FACP, does research for GSK Pharmaceuticals, Abbott Laboratories, and Merck. Associate Editor Dean L. Winslow, MD, FACP, FIDSA, serves as a consultant for Siemens Diagnostics, and is on the speaker's bureau for GSK and Cubist. Associate Editor Robert Muder, MD, does research for Aventis and Pharmacia.

Copyright 2010 AHC Media. All rights reserved.